OR WAIT null SECS
March 19, 2019
A $100-million investment will expand a range of the CDMO’s service capabilities and offerings.
March 18, 2019
The expansion includes a new R&D laboratory and the installation of a 12,000-liter reactor at one of the company’s manufacturing facilities on its Paullo site in Milan, Italy.
February 04, 2019
Keeping abreast of the latest industry trends and retaining flexibility are key to maintaining a strong market position.
February 02, 2019
Novel analytical methods may help biologics manufacturers respond to stricter regulations on particulate matter.
February 01, 2019
Tech transfer is key to succession advancing biopharmaceutical pipeline products from research to preclinical.
Outsourcing of analytical testing and processes can help bio/pharmaceutical companies expand their product profiles.
January 15, 2019
The company will invest $4 million to increase topical and transdermal formulation development and performance testing services at its Durham, NC, facility.
January 03, 2019
The $252-million acquisition is expected to strengthen Cambrex’s position as a small-molecule CDMO across the drug lifecycle.
The Massachusetts site, formerly associated with an affiliate of Shire, is Rentschler Biopharma’s first facility in the US.
December 14, 2018
The merged companies will provide histopathology services in the research and pre-clinical therapeutics markets.